Association Between the Proportion of Dominant Follicles and Oocyte Developmental Competence
Overview
Reproductive Medicine
Affiliations
Purpose: To explore the optimal timing for hCG triggering by investigating the impact of different proportion of dominant follicles on the oocyte developmental competence.
Methods: One hundred ninety-eight infertile women were divided into three groups according to the proportion of dominant follicles on hCG day: (1) low: <15% (n = 66); (2) middle: 15-27% (n = 66); (3) high: >27% (n = 66). The grouping criteria were the bottom and top tertiles of the proportion of dominant follicles.
Results: The gonadotropin dosage, duration and maximum follicle diameter in the low proportion group were lower than those in the middle and high proportion groups. Oocyte maturation and the abnormal fertilization rate in the low proportion group were lower than those in the middle and high proportion groups. The normal fertilization rate did not differ among the three groups. The cleavage rate and number of transferable embryos in the low proportion group were significantly higher than those in the high proportion group. The high-quality embryo rate, implantation rate, and pregnancy rate in the low proportion group were significantly higher than those in the middle and high proportion groups.
Conclusions: A high proportion of dominant follicles are closely associated with impaired oocyte developmental competence and low pregnancy rate. These findings suggest that follicular overgrowth induced by delayed hCG triggering may undermine oocyte developmental competence and the proportion of dominant follicles may be a potential parameters for hCG triggering.
Xie Q, Jiang W, Wei Y, Ni D, Yan N, Yang Y J Ovarian Res. 2024; 17(1):179.
PMID: 39217358 PMC: 11365273. DOI: 10.1186/s13048-024-01502-4.
Xie Q, Ni D, Chen S, Zhang W, Wang J, Ling X J Ovarian Res. 2024; 17(1):56.
PMID: 38444028 PMC: 10913352. DOI: 10.1186/s13048-024-01379-3.
Liu Y, Lin J, Shen X, Zhu Q, Kuang Y Front Endocrinol (Lausanne). 2023; 14:1072170.
PMID: 36936138 PMC: 10020617. DOI: 10.3389/fendo.2023.1072170.
Su H, Lai Y, Li J, Liao T, Ji L, Hu X J Ovarian Res. 2022; 15(1):44.
PMID: 35418089 PMC: 9006398. DOI: 10.1186/s13048-022-00973-7.
Kahraman S, Pirkevi Cetinkaya C, Cetinkaya M, Tufekci M, Gokhan Ekmekci C, Montag M Reprod Biol Endocrinol. 2018; 16(1):69.
PMID: 30031399 PMC: 6054838. DOI: 10.1186/s12958-018-0388-0.